Hims & Hers (HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular ...

With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move could jeopardize the availability of cheaper, generic forms of those drugs ...

Hims & Hers is launching a tracker of GLP-1 shortages to push back against the FDA's recent moves to end compounding copycats ...

The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...

Demand for Ozempic and other GLP-1 receptor agonist medications has soared recently due to their effectiveness for weight ...

Novo said supply of Wegovy and Ozempic is in good shape after the drugs were removed from the FDA’s shortage list last week.

Hims & Hers introduced a new tracker to monitor shortages of GLP-1 weight loss and diabetes drugs, responding to the FDA's decision to end the compounded versions, Yahoo Finance reported Nov. 13.

Semaglutide (GLP-1) weight-loss drug Wegovy ... diabetes drug Mounjaro and weight-loss drug Zepbound, off its shortage list.

Learn about GLP-1 medications, their benefits, risks and who should (or shouldn’t) consider using them. Design elements: Getty Images. Collage: Cassie Basford. Reviewed by Dietitian Jessica Ball ...